©2024 Stanford Medicine
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Recruiting
I'm InterestedTrial ID: NCT02418442
Purpose
Continuation of the CARRA Registry as described in the protocol will support data collection
on patients with pediatric-onset rheumatic diseases. The CARRA Registry will form the basis
for future CARRA studies. In particular, this observational registry will be used to answer
pressing questions about therapeutics used to treat pediatric rheumatic diseases, including
safety questions.
Official Title
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
1. Onset of rheumatic disease prior to age 16 years for JIA and onset prior to age 19
years for all other rheumatic diseases (see appendix A).
2. Subject (and/or parent/legal guardian when required) is able to provide written
informed consent and willing to comply with study procedures.
3. Subject and/or parent/legal guardian is willing to be contacted in the future by study
staff.
Exclusion Criteria:
1. Greater than 21 years of age at the time of enrollment.
Recruiting
I'm InterestedContact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Joseph Benavides